Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 104 entries
View as:

A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT06864143 Org: User:
Start: 03/07/25 End: 09/03/25 Due: 09/03/26

Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT04941144 Org: User:
Start: 12/22/21 End: 04/28/23 Due: 04/28/24

A Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05815498 Org: User:
Start: 03/28/23 End: 04/12/25 Due: 04/12/26

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05992935 Org: User:
Start: 08/25/23 End: 11/20/26 Due: 11/20/27

"The MaP Study": Mapping the Patient Journey in MMA and PA

Phase: N/A Priority: Normal
NCT ID: NCT03484767 Org: User:
Start: 03/20/18 End: 05/29/21 Due: 05/29/22

A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05333289 Org: User:
Start: 04/06/22 End: 11/22/22 Due: 11/22/23

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

Phase: N/A Priority: Normal
NCT ID: NCT06735248 Org: User:
Start: 04/16/25 End: 01/08/29 Due: 01/08/30

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT05375838 Org: User:
Start: 05/13/22 End: 12/29/22 Due: 12/29/23

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647

Phase: N/A Priority: Normal
NCT ID: NCT05105048 Org: User:
Start: 11/08/21 End: 08/10/23 Due: 08/10/24

A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT06060457 Org: User:
Start: 09/25/23 End: 06/07/24 Due: 06/07/25

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT06602024 Org: User:
Start: 09/16/24 End: 06/05/26 Due: 06/05/27

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

Phase: N/A Priority: Normal
NCT ID: NCT04159103 Org: User:
Start: 04/15/21 End: 01/31/26 Due: 01/31/27

A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05575492 Org: User:
Start: 11/07/22 End: 01/15/27 Due: 01/15/28

A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05127434 Org: User:
Start: 11/17/21 End: 08/25/25 Due: 08/25/26

Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03313778 Org: User:
Start: 08/14/17 End: 06/30/25 Due: 06/30/26

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

Phase: N/A Priority: Normal
NCT ID: NCT05164094 Org: User:
Start: 12/28/21 End: 10/05/26 Due: 10/05/27

Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03739931 Org: User:
Start: 11/27/18 End: 12/31/25 Due: 12/31/26

A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05249829 Org: User:
Start: 02/16/22 End: 06/23/23 Due: 06/23/24

A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06880549 Org: User:
Start: 03/25/25 End: 01/10/29 Due: 01/10/30

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

Phase: N/A Priority: Normal
NCT ID: NCT05130437 Org: User:
Start: 11/09/21 End: 12/04/31 Due: 12/04/32

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05436834 Org: User:
Start: 06/21/22 End: 10/27/25 Due: 10/27/26

A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04860297 Org: User:
Start: 04/16/21 End: 05/22/23 Due: 05/22/24

mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Phase: N/A Priority: Normal
NCT ID: NCT05918250 Org: User:
Start: 08/15/23 End: 05/27/26 Due: 05/27/27

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters

Phase: N/A Priority: Normal
NCT ID: NCT05137236 Org: User:
Start: 12/06/21 End: 03/23/23 Due: 03/23/24

Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03382405 Org: User:
Start: 11/13/17 End: 10/28/20 Due: 10/28/21